Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kasper, Aaboe"'
Autor:
Malene Lundgaard Riis, Gaspard Delpouve, John E. Nielsen, Cecilie Melau, Lea Langhoff Thuesen, Kristine Juul Hare, Eva Dreisler, Kasper Aaboe, Pia Tutein Brenøe, Jakob Albrethsen, Hanne Frederiksen, Anders Juul, Paolo Giacobini, Anne Jørgensen
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-19 (2024)
Abstract Sex-specific gonadal differentiation is directed by complex signalling promoting development in either male or female direction, while simultaneously inhibiting the opposite pathway. In mice, the WNT/β-catenin pathway promotes ovarian devel
Externí odkaz:
https://doaj.org/article/9ba84127f86e43e4b357207164f53583
Autor:
Malene Lundgaard Riis, Gabriele Matilionyte, John E. Nielsen, Cecilie Melau, David Greenald, Kristine Juul Hare, Lea Langhoff Thuesen, Eva Dreisler, Kasper Aaboe, Pia Tutein Brenøe, Anna-Maria Andersson, Jakob Albrethsen, Hanne Frederiksen, Ewa Rajpert-De Meyts, Anders Juul, Rod T. Mitchell, Anne Jørgensen
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-18 (2022)
Abstract Background Reduced androgen action during early fetal development has been suggested as the origin of reproductive disorders comprised within the testicular dysgenesis syndrome (TDS). This hypothesis has been supported by studies in rats dem
Externí odkaz:
https://doaj.org/article/6faa0696ef594229b30882d592bea05d
Autor:
Cecilie Melau, Berta Gayete Mor, Malene Lundgaard Riis, John E. Nielsen, Eva Dreisler, Kasper Aaboe, Pia Tutein Brenøe, Lea Langhoff Thuesen, Kristine Juul Hare, Rod T. Mitchell, Hanne Frederiksen, Anders Juul, Anne Jørgensen
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionAdministration of dexamethasone (DEX) has been used experimentally to suppress androgenization of external genitalia in 46,XX fetuses with congenital adrenal hyperplasia. Despite this, the prenatal biological mechanism-of-action of DEX on
Externí odkaz:
https://doaj.org/article/9b1a8f93d0f24ffb836d637b277bbce2
Autor:
Thure Krarup, Jens J. Holst, Tina Vilsbøll, Filip K. Knop, Kasper Aaboe, Sten Madsbad, Carolyn F. Deacon
Publikováno v:
Diabetes, Obesity and Metabolism. 12:323-333
Aim: To examine the effects of 12 weeks of treatment with the DPP-4 inhibitor, sitagliptin, on gastrointestinal hormone responses to a standardized mixed meal and beta cell secretory capacity, measured as glucose and non-glucose induced insulin secre
Publikováno v:
Diabetes, Obesity and Metabolism. 10:994-1003
Glucagon-like peptide 1 (GLP-1) is a gut-derived incretin hormone with the potential to change diabetes. The physiological effects of GLP-1 are multiple, and many seem to ameliorate the different conditions defining the diverse physiopathology seen i
Autor:
Katrine Dahl, Pedersen, Nathalie Søderhamn, Bülow, Kasper, Aaboe, Julie, Galsgaard, Helle Sand, Odgaard, Elisabeth Reinhardt, Mathiesen, Jeannet, Lauenborg
Publikováno v:
Ugeskrift for laeger. 177(50)
Polycystic ovary syndrome (PCOS) is associated with insulin resistance, infertility, obesity and gestational complications. Metformin is widely used in fertility treatment of women with PCOS, due to a suggested positive effect of continued metformin
Autor:
Torsten Lauritsen, Tina Vilsbøll, Jens J. Holst, Sten Madsbad, Henrik Agersø, Thure Krarup, Carolyn F. Deacon, Kasper Aaboe
Publikováno v:
Regulatory Peptides. 137:168-172
The incretin hormone, glucose-dependent insulinotropic polypeptide (GIP, previously known as gastric inhibitory polypeptide), is rapidly degraded to the biologically inactive metabolite GIP (3-42) in the circulation, but little is known about the kin
Publikováno v:
Diabetes, obesitymetabolism. 17(1)
Aims To examine whether 12 weeks of treatment with a dipeptidyl peptidase-4 (DPP-4) inhibitor, sitagliptin, influences the insulin secretion induced by glucose, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) du
Autor:
Sten Madsbad, Kasper Aaboe, Thure Krarup, Anders Vølund, Tina Vilsbøll, Filip K. Knop, J. J. Holst
Publikováno v:
Diabetes, obesitymetabolism. 14(6)
Aims: People with type 2 diabetes mellitus (T2DM) are characterized by reduced incretin effect and inappropriate glucagon levels. We evaluated α and β-cell responses to oral glucose tolerance test (OGTT) and isoglycaemic intravenous glucose infusio
Autor:
Kasper Aaboe, Jan Erik Henriksen, Sten Madsbad, David Hebbelstrup Jensen, J. J. Holst, Troels Magelund Krarup, Anders Vølund
Publikováno v:
Jensen, D H, Aaboe, K, Henriksen, J E, Vølund, A, Holst, J J, Madsbad, S & Krarup, T M 2012, ' Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes ', Diabetologia, vol. 55, no. 5, pp. 1406-16 . https://doi.org/10.1007/s00125-012-2459-7
The aim of this study was to evaluate the separate impact of insulin resistance and impaired glucose tolerance (IGT) on the incretin effect.Twenty-one healthy glucose-tolerant first-degree relatives of patients with type 2 diabetes underwent a 75 g O